OSTEOPOROSIS CLINICAL-FEATURES, PREVENTION, AND TREATMENT

被引:21
作者
GAMBERT, SR
SCHULTZ, BM
HAMDY, RC
机构
[1] SUNY HLTH SCI CTR, DEPT MED, BROOKLYN, NY 11203 USA
[2] LONG ISL COLL HOSP, DEPT MED, DIV GERONTOL & GERIATR MED, BROOKLYN, NY 11201 USA
[3] E TENNESSEE STATE UNIV, JAMES H QUILLEN COLL MED, DIV GERIATR MED, JOHNSON CITY, TN 37614 USA
[4] VET AFFAIRS MED CTR, DEPT GERIATR & EXTENDED CARE, MOUNTAIN HOME, TN USA
关键词
D O I
10.1016/S0889-8529(18)30044-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoporosis is a condition resulting in an increased risk of skeletal fractures due to a reduction in the volume of bone tissue. Although it may occur at any age, osteoporosis is most commonly found in the mature adult skeleton. Osteopenia is a term denoting a reduction in bone volume; osteoporosis (porous bone) specifies a specific form of osteopenia which is accompanied by cortical porosity. Osteoporosis leads to a reduction in absolute bone volume in association with a normal ratio of unmineralized to mineralized bone matrix. It must be differentiated from the other major form of osteopenia affecting adults, osteomalacia, which is associated with an increase in the ratio of unmineralized to mineralized bone matrix.
引用
收藏
页码:317 / 371
页数:55
相关论文
共 323 条
[1]  
ALBRIGHT FULLER, 1940, TRANS ASSOC AMER PHYSICIANS, V55, P298
[2]   COMBINATION THERAPY FOR OSTEOPOROSIS [J].
ALOIA, JF ;
ZANZI, I ;
VASWANI, A ;
ELLIS, K ;
COHN, SH .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1977, 26 (07) :787-792
[3]   TREATMENT OF OSTEOPOROSIS WITH CALCITONIN, WITH AND WITHOUT GROWTH-HORMONE [J].
ALOIA, JF ;
VASWANI, A ;
KAPOOR, A ;
YEH, JK ;
COHN, SH .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1985, 34 (02) :124-129
[4]   COHERENCE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH GROWTH-HORMONE AND CALCITONIN [J].
ALOIA, JF ;
VASWANI, A ;
MEUNIER, PJ ;
EDOUARD, CM ;
ARLOT, ME ;
YEH, JK ;
COHN, SH .
CALCIFIED TISSUE INTERNATIONAL, 1987, 40 (05) :253-259
[5]   COMBINATION THERAPY FOR OSTEOPOROSIS WITH ESTROGEN, FLUORIDE, AND CALCIUM [J].
ALOIA, JF ;
ZANZI, I ;
VASWANI, A ;
ELLIS, K ;
COHN, SH .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1982, 30 (01) :13-17
[6]   EFFECTS OF GROWTH-HORMONE IN OSTEOPOROSIS [J].
ALOIA, JF ;
ZANZI, I ;
ELLIS, K ;
JOWSEY, J ;
ROGINSKY, M ;
WALLACH, S ;
COHN, SH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1976, 43 (05) :992-999
[7]   ROLE OF CALCITRIOL IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS [J].
ALOIA, JF .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (04) :35-38
[8]   CHANGES IN BODY-COMPOSITION FOLLOWING THERAPY OF OSTEOPOROSIS WITH METHANDROSTENOLONE [J].
ALOIA, JF ;
KAPOOR, A ;
VASWANI, A ;
COHN, SH .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1981, 30 (11) :1076-1079
[9]   CALCITRIOL IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS [J].
ALOIA, JF ;
VASWANI, A ;
YEH, JK ;
ELLIS, K ;
YASUMURA, S ;
COHN, SH .
AMERICAN JOURNAL OF MEDICINE, 1988, 84 (03) :401-408
[10]   PREMENOPAUSAL BONE MASS IS RELATED TO PHYSICAL-ACTIVITY [J].
ALOIA, JF ;
VASWANI, AN ;
YEH, JK ;
COHN, SH .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (01) :121-123